Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review

Cardiovascular (CV) events in patients with cancer can be caused by concomitant CV risk factors, cancer itself, and anticancer therapy. Since malignancy can dysregulate the hemostatic system, predisposing cancer patients to both thrombosis and hemorrhage, the administration of dual antiplatelet ther...

Full description

Bibliographic Details
Main Authors: Grigorios Tsigkas, Angeliki Vakka, Anastasios Apostolos, Eleni Bousoula, Nikolaos Vythoulkas-Biotis, Eleni-Evangelia Koufou, Georgios Vasilagkos, Ioannis Tsiafoutis, Michalis Hamilos, Adel Aminian, Periklis Davlouros
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
cancer
acute coronary syndrome (ACS)
percutaneous coronary intervention (PCI)
dual antiplatelet therapy (DAPT)
triple antithrombotic therapy (TAT)
atrial fibrillation (AF)
Online Access:https://www.mdpi.com/2308-3425/10/4/135

Internet

https://www.mdpi.com/2308-3425/10/4/135

Similar Items